Privosegtor is an investigational new drug that is being evaluated by Oculis Pharma for the treatment of optic neuritis. It is a serine/threonine-protein kinase SGK2 activator that is claimed to have neuroprotective properties.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.